Search Results

Teva s Global R D organization is devoted to the development of new medicines devices and combination products that provide meaningful therapeutic benefit

For the past seven years we have collaborated with the Healthcare Business Women s Association HBA to help support and advance women in our organization through its Rising Star and Luminary Program

From the increased incorporation of patient perspectives to the growing rise of technology in research Teva s Head of Global Early Clinical Development Eran Harary outlines the trends he s watching